Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
Dr Vijaya Kumar has a depth of experience in manufacturing science, plant and process engineering, process analytics, plant automation, regulatory frameworks, and CAPEX management
Sami-Sabinsa Group, a multi-national health science company headquartered in Bengaluru, has announced the appointment of Dr Vijaya Kumar S as its Chief Executive Officer.
A well-known and respected professional in the industry, Dr Vijaya Kumar has a proven track record of fostering sustainable business growth in the pharmaceutical space. He has held leadership positions across large organisations such as Saurav Chemicals, Biocon, Centrient, Aurobindo, Dr Reddy’s, Mckinsey, Novartis, GSK, and others.
With an illustrious career of 35 years in research and development, manufacturing, operations, and management, he brings a wealth of experience to his new role as the CEO of Sami-Sabinsa Group.
Dr Vijaya Kumar has a depth of experience in manufacturing science, plant and process engineering, process analytics, plant automation, regulatory frameworks, and CAPEX management.
Dr Vijaya Kumar has completed his postgraduate in management from the National University of Singapore and holds a doctorate in chemical engineering from the Indian Institute of Science (IISc).